HAYA Therapeutics
Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. Patients Ground Us.
68 employees · est. 2019 · Switzerland
Silverback Therapeutics is the older company (2019 vs 2016); HAYA Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | HAYA Therapeutics | Silverback Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2016 older |
| Headquarters | ||
| Headquarters | Switzerland | Not tracked yet |
| Employees | ||
| Employees | 68 larger | 7 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Undisclosed | Series C |
| Total Funding | ||
| Total Funding | $1.02B | $221.00M |
| Funding Rounds | ||
| Funding Rounds | 9 | 5 |
| Services | ||
| Services | Development of precise RNA therapies for reprogramming disease driving cell-states | needle-free epinephrine nasal spray development, patient support and savings programs, pharmaceutical product innovation |
| Target Customers | ||
| Target Customers | Patients suffering from rare and chronic diseases | patients requiring epinephrine, caregivers of patients, healthcare providers |
| Taxonomy | ||
| Taxonomy | RNA-based Therapeutics, Precision Medicine, Cardiovascular Disease Treatment, Cancer Treatment, Long Non-coding RNAs (lncRNAs), Cell-specific Therapeutics, Biopharmaceutical Therapy, Genomic Medicines, Fibrosis Treatment, Disease-modifying Therapeutics | Biopharmaceutical Company, Clinical-stage, ImmunoTAC Technology, Tissue Targeted Therapeutics, Cancer Treatment, Viral Infections Treatment, Immuno-oncology Agents, Myeloid Cell Activator, Solid Tumors, Antibody-guided Approach, Immuno-modulatory Pathways, Systemically Delivered Therapies, Disease-specific Targeting, R&D Approach, Potent Modulators |
| Website | ||
| Website | hayatx.com | silverbacktx.com |
About HAYA Therapeutics
HAYA Therapeutics is a precision medicines company focused on developing RNA-guided programmable therapeutics targeting the regulatory genome to address serious health conditions such as cardiovascular disease and cancer. The company's innovative cell-state modifying platform provides novel insights...
About Silverback Therapeutics
Silverback Therapeutics is a clinical-stage biopharmaceutical company, established in 2016, centered around its proprietary ImmunoTAC technology platform. The company focuses on developing systemic, tissue-targeted therapeutics designed for treating cancer, chronic viral infections, and other seriou...
We will tell you when either one moves
BounceWatch watches HAYA Therapeutics and Silverback Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at HAYA Therapeutics and Silverback Therapeutic... — by email.
Frequently Asked Questions
Compare HAYA Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at HAYA Therapeutics on 9 Jun 2026, and Silverback Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
